BOSTON, March 30, 2017 /PRNewswire/ --
IDTechEx Research, a leading provider of independent market research, businessintelligence and events on emerging technology, announces the availability of a brand new report, Technologies for Diabetes Management 2017-2027: Forecasts, Players, Opportunities.
Technologies for Diabetes Management 2017-2027: Forecasts,
(Logo: http://photos.prnewswire.com/prnh/20140310/673848 )
(Photo: http://mma.prnewswire.com/media/483921/IDTechEx_Diabetes_Infographic.jpg )
People with diabetes have traditionally self-monitored their glucose levels using disposable biosensors and invasive sampling techniques. While this industry has been one of the success stories of the printed electronics industry, worth around $6 billion today, profitability is falling as government reimbursement models are changing and strain is put on both consumers and manufacturers. However new methods of glucose monitoring are emerging. These technologies are analysed comprehensively in this IDTechEx report.
Companies are investigating the potential for glucose testing in sweat, tears and saliva with varying levels of success and these projects are also analysed in the report.
This report is of key importance to innovators in medical device technology as well as players in the printed electronics, sensor, and wearable industries. It highlights the significant factors that have been essential for the development of successful devices for diabetes management as well as analysing devices that have been unsuccessful in the commercial field.
The report examines diabetes technologies across 7 key areas: sensors for glucose monitoring; beyond blood glucose measurements; sensors for Ketone monitoring; smart insulin pens; insulin pumps: towards an artificial pancreas; sensors for side effects; and sensors for early diagnosis.
The report contains 10 year forecasts across all relevant market segments, detailing revenue predictions, and volumes across multiple sensing technologies.
IDTechEx has identified and profiled key players to build a comprehensive picture of the diabetes technology industry. Significant stakeholders have been identified and profiled through primary research and interviews to understand the technology roadmap of diabetes care and to give an insightful, contextual and timely analysis of the industry now and in the future, identifying factors crucial for the triumph of a company in this ever-growing field.
Find out more at http://www.IDTechEx.com/diabetes.
Contact: Alison Lewis Marketing Manager, Reports a.lewis@IDTechEx.com UK: +44-(0)1223-810290
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All